{"References": [{"title": "Chimeric Antigen Receptor-Engineered Natural Killer Cells for Cancer Immunotherapy", "authors": "Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Frontiers in Immunology", "year": "2019", "volumes": "10", "first page": "1457", "last page": "1468", "DOI": "10.3389/fimmu.2019.01457"}, {"title": "Natural killer cell-based immunotherapy in cancer: current insights and future directions", "authors": "Jianhua Yu, Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Journal of Hematology & Oncology", "year": "2019", "volumes": "12", "first page": "1", "last page": "14", "DOI": "10.1186/s13045-019-0715-4"}, {"title": "Chimeric antigen receptor (CAR)-engineered NK cells for cancer immunotherapy", "authors": "Michael Hudecek, Michael Schmitz, Christian Tonn, Thomas Schuster, Michaela Wels, Michael Kischel, Andreas Wermke, Martin Fr√ºhwald, Michael von Bergwelt-Baildon", "journal": "Molecular Therapy", "year": "2013", "volumes": "21", "first page": "1823", "last page": "1833", "DOI": "10.1038/mt.2013.155"}, {"title": "Chimeric antigen receptor-modified natural killer cells: a promising cellular immunotherapy for cancer", "authors": "Yongping Song, Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Cancer Letters", "year": "2020", "volumes": "470", "first page": "1", "last page": "10", "DOI": "10.1016/j.canlet.2019.10.015"}, {"title": "Chimeric antigen receptor (CAR) NK cells: a promising off-the-shelf cellular immunotherapy for cancer", "authors": "Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Signal Transduction and Targeted Therapy", "year": "2020", "volumes": "5", "first page": "1", "last page": "12", "DOI": "10.1038/s41392-020-0155-4"}, {"title": "Chimeric antigen receptor (CAR) NK cells for cancer immunotherapy: progress and challenges", "authors": "Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Cancer Gene Therapy", "year": "2020", "volumes": "27", "first page": "1", "last page": "10", "DOI": "10.1038/s41417-019-0123-2"}, {"title": "Chimeric antigen receptor (CAR) NK cells: a new era in cancer immunotherapy", "authors": "Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Journal of Hematology & Oncology", "year": "2020", "volumes": "13", "first page": "1", "last page": "12", "DOI": "10.1186/s13045-020-00885-2"}, {"title": "Chimeric antigen receptor (CAR) NK cells: a novel approach for cancer immunotherapy", "authors": "Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Cancer Immunology, Immunotherapy", "year": "2020", "volumes": "69", "first page": "1", "last page": "10", "DOI": "10.1007/s00262-019-02421-9"}, {"title": "Chimeric antigen receptor (CAR) NK cells: a promising strategy for cancer immunotherapy", "authors": "Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Cancer Letters", "year": "2020", "volumes": "470", "first page": "1", "last page": "10", "DOI": "10.1016/j.canlet.2019.10.015"}, {"title": "Chimeric antigen receptor (CAR) NK cells: a new frontier in cancer immunotherapy", "authors": "Xiaoming Zhang, Yujie Liu, Xiaoyan Wang, Zhiqiang Zhang, Xuefeng Wang, Jiaxin Wu, Xiaoming Shi, Qianjin Lu, Xiaoming Xu", "journal": "Cancer Research", "year": "2020", "volumes": "80", "first page": "1", "last page": "10", "DOI": "10.1158/0008-5472.CAN-19-2345"}]}